BRIEF-Biocryst’s Rapivab receives FDA approval for a pediatric indication By: Reuters: Company News September 21, 2017 at 06:22 AM EDT * Biocryst’s Rapivab (peramivir injection) receives FDA approval for a pediatric indication Read More >> Related Stocks: Biocryst Pharma Inc